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Seroprevalence of major blood-borne infections among blood
donors in Kano, Nigeria
Emmanuel NWANKWO1, Imoru MOMODU2, Ismaila UMAR3, Babashani MUSA4, Solomon ADELEKE5

Aim: To examine the seroprevalence of common blood infections among blood donors, which remains a major concern
in transfusion medicine in Nigeria. Blood transfusion is one of the known therapeutic interventions that cut across a
number of clinical disciplines.
Materials and methods: The seroprevalences of human immunodeficiency virus (HIV), hepatitis C virus (HCV),
hepatitis B surface antigen (HBsAg), and syphilis among 280 blood donors at the Murtala Mohammed Specialist
Hospital (MMSH) were determined. The seroprevalences of the pathogens were determined with regard to age, sex,
donor category, and occurrence of association pathogens. Between June and December 2008, 276 males (98.6%) and 4
females (1.4%), with an age range of 18-54 years, donated blood.
Results: Tests showed that 54 (19.3%) donors had serological evidence of infection with at least one pathogen, while 8
(2.9%) had multiple infections. The seroprevalences of syphilis, HBsAg, HCV, and HIV were found to be 7.5%, 11.1%,
1.8%, and 1.4%, respectively, at the MMSH in Kano. The age group of 28-37 years had the highest rates of syphilis (8.7%),
HBsAg (15.5%), and HIV (2.9%), while the age group of 18-27 years had the highest prevalence of HCV (2.5%).
Conclusion: The high (19.3%) seroprevalence of transfusion-transmissible infections in blood donated at the MMSH
calls for comprehensive screening of blood donors for HBsAg, HCV, HIV, and syphilis using sensitive techniques and
strict selection criteria of donors.
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Introduction
Over a million blood units are collected from donors every year, and many more millions still need
to be collected to meet global demand and ensure sufficient and timely provision of blood (1).
Blood transfusion is one of the known therapeutic interventions that cut across a number of
clinical disciplines but the practice is not without risks, as 10%-15% of HIV transmission in Africa
has been through blood transfusion (2,3).
Hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV),
and syphilis infections are public health problems that share similar routes of transmission such
as sexual contact, exposure to contaminated blood or blood products, the dangerous tradition of
sharing needles, intravenous drug use, and transfer from mother to child (4-6). HBV and HCV
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infections have been associated with long-term
morbidity and mortality due to complications like
cirrhosis, portal hypertension, chronic liver diseases,
and hepatocellular carcinoma (7-9), but in HIV
infection, it accelerates the progression of HBV- and
HCV-related chronic liver disease (10).
Reports from different parts of the world vary,
with prevalences of HBsAg, HCV, HIV, and syphilis
among blood donors of 0.66%-25%, 1.0%-13.3%,
0.084%-11.7%, and 0.95%-4.7%, respectively (4,1113), while, in Nigeria, prevalences of 1.3%-1.49%, 6%8.4%, 1.1%-5.8%, and 0.1%-3.6% have been reported
for HBsAg, HCV, HIV, and syphilis, respectively (1419).
Murtala Mohammed Specialist Hospital (MMSH)
is the largest state government hospital in the state
of Kano and it is situated in the city of Kano, where
most of the patients from all over the state seek
medical attention because the charges are relatively
affordable. It renders blood transfusion as one of
the routine services. Most of the donated blood in
the past was screened for HIV and HBsAg, until
recently, when HCV screening was also introduced.
The present study has become necessary due to the
paucity of information regarding the seroprevalence
of common blood infections among blood donors in
Kano.
Materials and methods
Type of study: Descriptive cross-section.
The blood samples of 280 donors (voluntary,
replacement, and commercial donors), consisting of
276 healthy men and 4 nonpregnant, nonlactating
women, aged between 18 and 54 years and weighing
≥50 kg, were collected into plain containers and
studied at the MMSH, Kano, between June and
December 2008. The sera obtained after centrifugation
were analyzed immediately.
Assays
HIV serology: HIV status was determined with
DETERMINE HIV 1/2 (Abbott Japan Co. Ltd.,
Tokyo, Japan) and reactive samples were retested
with STAT-PAK (Caldon Biotech, Inc., Carlsbad,
CA, USA). These assays detect both HIV-1 and HIV2 infections.
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HCV serology: IgG antibodies to HCV were
detected using the HBsAg Kit (ACON Laboratories,
Inc., San Diego, CA, USA). Results were interpreted
according to the manufacturer’s instructions.
Syphilis serology: Syphilis was diagnosed using
the Venereal Disease Research Laboratory test (CDI
Cal-Tech Diagnostics, Inc., Chino, CA, USA) and
the Treponema pallidum hemagglutination test (CDI
Cal-Tech Diagnostics, Inc.). Active syphilis was
diagnosed if an individual’s blood tested positive
with both tests.
Detection of HBsAg: HBsAg was detected using
the HBsAg Kit (ACON Laboratories, Inc.). Results
were interpreted according to the manufacturer’s
instructions.
Statistical analysis: The seroprevalences of
HIV, HCV, HBsAg, and syphilis were expressed in
percentages for the entire study group. Comparisons
between the donor categories were done using chisquare and P < 0.05 was considered significant, while
the odds ratio (OR) was employed to determine the
association in the occurrence of syphilis, HBsAg,
HCV, and HIV.
Results
For this study, a total of 280 blood donors were
recruited, 276 (98.6%) males and 4 (1.4%) females
aged between 18 and 54 years. Of these donors,
157 (56.1%) were family replacement donors, while
commercial and voluntary donors were 62 (22.1%)
and 61 (21.8%), respectively.
Of the donated blood, 54 (19.3%) samples had
serological evidence of infection with at least 1
pathogen, while 8 (2.9%) had multiple infections,
with the association of syphilis and HBsAg occurring
most frequently.
Table 1 shows the seroprevalences of syphilis,
HBsAg, HCV, and HIV among the 280 blood donors
to be 7.5%, 11.1%, 1.8%, and 1.4%, respectively. The
age group of 28-37 years had the highest prevalences
of syphilis (8.7%), HBsAg (15.5%), and HIV (2.9%),
while the age group of 18-27 years had the highest
prevalence of HCV (2.5%). The prevalences of
syphilis, HBsAg, HCV, and HIV were, respectively,
7.6%, 10.9%, 1.8%, and 1.4% for males and 0%, 25%,
0%, and 0% for females.
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Table 1. Seroprevalences of major blood-borne infections with regard to age and sex of blood donors.

Total number of
samples (%)

Number of positive cases (%)
Syphilis
(%)

HBsAg
(%)

HCV
(%)

HIV
(%)

Age (years)
18-27

122 (43.6)

10 (8.2)

11 (9.0)

3 (2.5)

0 (0)

28-37

103 (36.8)

9 (8.7)

16 (15.5)

2 (1.9)

3 (2.9)

38-47

46 (16.4)

2 (4.3)

5 (10.9)

0 (0)

0 (0)

48-54

9 (3.2)

0 (0)

0 (0)

0 (0)

0 (0)

18-54

280 (100)

21 (7.5)

31 (11.1)

5 (1.8)

4 (1.4)

276 (98.6)

21 (7.6)

30 (10.9)

5 (1.8)

4 (1.4)

4 (1.4)

0 (0)

1 (25)

0 (0)

0 (0)

Sex
Male
Female

statistically significant (P > 0.05), as they were for
syphilis (χ2 = 4.115, df 2), HBsAg (χ2 = 1.66, df 2),
HCV (χ2 = 4.528, df 2), and HIV (χ2 = 0.892, df 2).

Table 2 shows the prevalences of transfusionassociated viral infections and syphilis in the 3
blood donor categories. The prevalences of syphilis,
HBsAg, HCV, and HIV were 12.9%, 12.9%, 4.8%,
and 1.6%, respectively, for commercial donors; 5.7%
12.1%, 0.6%, and 1.3%, respectively, for replacement
donors; and 4.9%, 6.6%, 1.6%, and 0%, respectively,
for voluntary donors. However, the differences in the
prevalences with regard to donor categories were not

Table 3 shows positive associations in the
occurrence of HCV and HIV (OR = 22.7, 95% CI 1.9268.0), syphilis and HBsAg (OR = 1.9, 95% CI 0.66.0), syphilis and HIV (OR = 4.1, 95% CI 0.4-40.0),
and HBsAg and HCV (OR = 5.7, 95% CI 0.9-35.3).

Table 2. Prevalences of transfusion-associated viral infections and syphilis in 3 blood donor categories.
Number of positive cases (%)
Donor category

Total number of
samples (%)

Syphilis
(%)

HBsAg
(%)

HCV
(%)

HIV
(%)

Commercial donors

62 (22.1)

8 (12.9)

8 (12.9)

3 (4.8)

1 (1.6)

Replacement donors

157 (56.1)

9 (5.7)

19 (12.1)

1 (0.6)

2 (1.3)

Voluntary donors

61 (21.8)

3 (4.9)

4 (6.6)

1 (1.6)

0 (0)

>0.05

>0.05

>0.05

>0.05

P-value

Table 3. Association in the occurrence of syphilis, HBsAg, HCV, and HIV in 280 blood donors using odds ratio
(OR) with 95% confidence interval (CI).
Infections

Number of positive results

Percentage (%) positivity

OR (95% CI)

HCV and HIV

1

0.4

22.7 (1.9-268)

Syphilis and HBsAg

4

1.4

1.9 (0.6-6.0)

Syphilis and HIV

1

0.4

4.1 (0.4-40.0)

HBsAg and HCV

2

0.7

5.7 (0.9-35.3)
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Discussion
The need for the screening of blood for syphilis,
HBsAg, HCV, and HIV cannot be overemphasized,
as this study has shown that almost 1 of the 5 (19.3%)
units of blood donated had serological evidence of
infection with at least 1 pathogen. This is quite high
and therefore calls for proper screening of donated
blood with sensitive and specific reagents coupled
with stringent donor selection criteria.
This study shows overall seroprevalences of 7.5%,
11.1%, 1.8%, and 1.4% for syphilis, HBsAg, HCV, and
HIV, respectively, while 2.9% of the donated units of
blood had serological evidence of multiple infections,
with the association of syphilis and HBsAg having the
highest occurrence. These findings are comparable
to previous reports in Nigeria (14-19); however, the
high prevalence of syphilis (7.5%) in blood donors
in this study is a matter of concern, as most of the
federal and state government hospitals in Nigeria are
yet to embrace its screening. Treponema palladium,
which causes syphilis, rarely survives in whole blood
or blood products refrigerated at 2-8 °C after 96 h
(20), but there are occasions when blood is transfused
immediately after it is donated. If the donor is infected
with syphilis, this will be transferred to the recipient.
Moreover, its transmission contributes to very high
exposure to infections such as HIV and hepatitis,
since it is also sexually transmitted (21).
This study has also shown that commercial or
paid donors had the highest prevalences of syphilis,
HBsAg, HCV, and HIV, at 12.9%, 12.9%, 4.8%, and
1.6%, respectively, as compared to 5.7%, 12.1%, 0.6%,
and 1.3%, respectively, for the family replacement
donors and 4.9%, 6.6%, 1.6%, and 0%, respectively,
for voluntary donors, though the differences were
not statistically significant. These findings, which are

in agreement with earlier reports (12,13,19), indicate
that commercial donors are less suitable for blood
donation than family replacement and voluntary
donors. The increase in the prevalence of transfusiontransmissible infections in commercial donors has
been attributed to socioeconomic and environmental
factors coupled with donors’ concealment of their
true state of health before donation (22,23).
In addition to screening blood donors using
sensitive techniques, increased seroprevalences of
HIV, HBsAg, HCV, and syphilis can be reduced using
comprehensive evaluation of self- exclusion forms
and clinical evaluation (24).
With regard to the occurrence of the pathogens,
there were significant positive associations between
HCV and HIV, HBsAg and HCV, syphilis and HIV,
and syphilis and HBsAg. These associations of the
pathogens could have been sexually transmitted;
moreover, lesions from syphilis could enhance
transmission of transfusion-transmissible infections
(25).
Conclusion
The high (19.3%) seroprevalence of transfusiontransmissible infections in blood donated at the
MMSH is alarming and, therefore, calls for proper
screening of blood for HIV, HBsAg, HCV, and
syphilis with sensitive and specific reagents; if
possible, nucleic acid technology should be employed
(21,26). Strict selection of blood donors; public
enlightenment on HIV, HBsAg, HCV, and syphilis
infections; and prevention strategies should be
strengthened. Motivation of voluntary donors should
be encouraged and legalized by the government, as is
practiced in other countries (27,28).
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